Literature DB >> 19362065

A cellular model for screening neuronal nitric oxide synthase inhibitors.

Jianguo Fang1, Richard B Silverman.   

Abstract

Nitric oxide synthase (NOS) inhibitors are potential drug candidates because it has been well demonstrated that excessive production of nitric oxide critically contributes to a range of diseases. Most inhibitors have been screened in vitro using recombinant enzymes, leading to the discovery of a variety of potent compounds. To make inhibition studies more physiologically relevant and bridge the gap between the in vitro assay and in vivo studies, we report here a cellular model for screening NOS inhibitors. Stable transformants were generated by overexpressing rat neuronal NOS in HEK 293T cells. The enzyme was activated by introducing calcium ions into cells, and its activity was assayed by determining the amount of nitrite that was formed in culture medium using the Griess reagent. We tested a few NOS inhibitors with this assay and found that the method is sensitive, versatile, and easy to use. The cell-based assay provides more information than in vitro assays regarding the bioavailability of NOS inhibitors, and it is suitable for high-throughput screening.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362065      PMCID: PMC2688442          DOI: 10.1016/j.ab.2009.04.004

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  39 in total

1.  Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.

Authors:  Roman Fedorov; Ryan Vasan; Dipak K Ghosh; Ilme Schlichting
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

2.  1,1-Dimethylallylcoumarins potently suppress both lipopolysaccharide- and interferon-gamma-induced nitric oxide generation in mouse macrophage RAW 264.7 cells.

Authors:  A Murakami; G Gao; M Omura; M Yano; C Ito; H Furukawa; D Takahashi; K Koshimizu; H Ohigashi
Journal:  Bioorg Med Chem Lett       Date:  2000-01-03       Impact factor: 2.823

3.  Nitric-oxide synthase assays.

Authors:  J M Hevel; M A Marletta
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Mechanism of action of some inhibitors of endothelium-derived relaxing factor.

Authors:  S Moncada; R M Palmer; R J Gryglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase.

Authors:  J M Hah; L J Roman; P Martásek; R B Silverman
Journal:  J Med Chem       Date:  2001-08-02       Impact factor: 7.446

Review 6.  Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

Authors:  L Salerno; V Sorrenti; C Di Giacomo; G Romeo; M A Siracusa
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

7.  S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.

Authors:  Kenny K K Chung; Bobby Thomas; Xiaojie Li; Olga Pletnikova; Juan C Troncoso; Laura Marsh; Valina L Dawson; Ted M Dawson
Journal:  Science       Date:  2004-04-22       Impact factor: 47.728

8.  Substituted 6-phenyl-pyridin-2-ylamines: selective and potent inhibitors of neuronal nitric oxide synthase.

Authors:  Deane M Nason; Steven D Heck; Mathew S Bodenstein; John A Lowe; Robert B Nelson; Dane R Liston; Charles E Nolan; Lorraine F Lanyon; Karen M Ward; Robert A Volkmann
Journal:  Bioorg Med Chem Lett       Date:  2004-09-06       Impact factor: 2.823

9.  Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.

Authors:  Haitao Ji; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

10.  Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.

Authors:  E S Furfine; M F Harmon; J E Paith; R G Knowles; M Salter; R J Kiff; C Duffy; R Hazelwood; J A Oplinger; E P Garvey
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

View more
  10 in total

1.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

2.  Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jianguo Fang; Silvia L Delker; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2011-03-16       Impact factor: 7.446

3.  Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.

Authors:  He Huang; Haitao Ji; Huiying Li; Qing Jing; Kristin Jansen Labby; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2012-07-10       Impact factor: 15.419

4.  Smooth muscle relaxation and activation of the large conductance Ca(++)-activated K+ (BK(Ca)) channel by novel oestrogens.

Authors:  J Maher; A C Hunter; J G Mabley; J Lippiat; M C Allen
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

5.  Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.

Authors:  Fengtian Xue; Jianguo Fang; William W Lewis; Pavel Martásek; Linda J Roman; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2009-11-22       Impact factor: 2.823

6.  Zhankuic acid A isolated from Taiwanofungus camphoratus is a novel selective TLR4/MD-2 antagonist with anti-inflammatory properties.

Authors:  Yu-Fon Chen; Ai-Li Shiau; Sheng-Hung Wang; Jai-Sing Yang; Sue-Joan Chang; Chao-Liang Wu; Tian-Shung Wu
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

7.  Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans.

Authors:  Dean L Kellogg; Joan L Zhao; Yubo Wu
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

8.  S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation.

Authors:  Roshan Kumar; Deepak K Jangir; Garima Verma; Shashi Shekhar; Pranita Hanpude; Sanjay Kumar; Raniki Kumari; Nirpendra Singh; Neel Sarovar Bhavesh; Nihar Ranjan Jana; Tushar Kanti Maiti
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

9.  On the selectivity of neuronal NOS inhibitors.

Authors:  B Pigott; K Bartus; J Garthwaite
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.

Authors:  Maris A Cinelli; Huiying Li; Georges Chreifi; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2014-02-10       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.